Literature DB >> 12662399

Cell-free nucleic acids in plasma, serum and urine: a new tool in molecular diagnosis.

Allen K C Chan1, Rossa W K Chiu, Y M Dennis Lo.   

Abstract

There has recently been an upsurge of interest in the analysis of circulating nucleic acids (DNA and/or RNA) in blood plasma or serum as a clinical diagnostic tool. Occasional earlier reports suggested the existence of circulating nucleic acids, but the potential clinical implication was not realized until 1996, when DNA with tumour-specific characteristics was demonstrated in the plasma/serum of cancer patients. This finding opened up possibilities for non-invasive cancer diagnosis. Potential applications have been reported in cancer diagnosis, prenatal diagnosis, transplantation and traumatology. Some of the findings are on the verge of being translated into clinical use. DNA is also now being sought in other body fluids such as urine.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12662399     DOI: 10.1258/000456303763046030

Source DB:  PubMed          Journal:  Ann Clin Biochem        ISSN: 0004-5632            Impact factor:   2.057


  33 in total

1.  A simple method of genomic DNA extraction from human samples for PCR-RFLP analysis.

Authors:  Souvik Ghatak; Rajendra Bose Muthukumaran; Senthil Kumar Nachimuthu
Journal:  J Biomol Tech       Date:  2013-12

2.  A locked nucleic acid clamp-mediated PCR assay for detection of a p53 codon 249 hotspot mutation in urine.

Authors:  Selena Y Lin; Veerpal Dhillon; Surbhi Jain; Ting-Tsung Chang; Chi-Tan Hu; Yih-Jyh Lin; Shun-Hua Chen; Kung-Chao Chang; Wei Song; Lixin Yu; Timothy M Block; Ying-Hsiu Su
Journal:  J Mol Diagn       Date:  2011-07-02       Impact factor: 5.568

3.  Diagnostic and prognostic value of cell free circulating Schistosoma mansoni DNA: an experimental study.

Authors:  Maysa Ahmad Eraky; Nagwa Shaban Mohamed Aly
Journal:  J Parasit Dis       Date:  2014-12-20

4.  Circulating cell-free high mobility group AT-hook 2 mRNA as a detection marker in the serum of colorectal cancer patients.

Authors:  Sana Sahengbieke; Jian Wang; Xiangwei Li; Yuhong Wang; Maode Lai; Jingjing Wu
Journal:  J Clin Lab Anal       Date:  2017-09-26       Impact factor: 2.352

Review 5.  Pondering neutrophil extracellular traps with healthy skepticism.

Authors:  William M Nauseef; Paul Kubes
Journal:  Cell Microbiol       Date:  2016-08-23       Impact factor: 3.715

6.  The prognostic value of circulating plasma DNA level and its allelic imbalance on chromosome 8p in patients with hepatocellular carcinoma.

Authors:  Ning Ren; Lun-Xiu Qin; Hong Tu; Yin-Kun Liu; Bo-Heng Zhang; Zhao-You Tang
Journal:  J Cancer Res Clin Oncol       Date:  2006-02-25       Impact factor: 4.553

7.  Detection of Dirofilaria immitis DNA in host serum by nested PCR.

Authors:  Masaaki Oi; Yukita Sato; Kazuhide Nakagaki; Sadao Nogami
Journal:  Parasitol Res       Date:  2015-06-26       Impact factor: 2.289

Review 8.  Clinical applications of urinary cell-free DNA in cancer: current insights and promising future.

Authors:  Tian Lu; Jinming Li
Journal:  Am J Cancer Res       Date:  2017-11-01       Impact factor: 6.166

Review 9.  DNA markers in molecular diagnostics for hepatocellular carcinoma.

Authors:  Ying-Hsiu Su; Selena Y Lin; Wei Song; Surbhi Jain
Journal:  Expert Rev Mol Diagn       Date:  2014-08-07       Impact factor: 5.225

10.  Cell-free DNA Comprises an In Vivo Nucleosome Footprint that Informs Its Tissues-Of-Origin.

Authors:  Matthew W Snyder; Martin Kircher; Andrew J Hill; Riza M Daza; Jay Shendure
Journal:  Cell       Date:  2016-01-14       Impact factor: 41.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.